Cargando…
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759802/ https://www.ncbi.nlm.nih.gov/pubmed/35026843 http://dx.doi.org/10.1182/bloodadvances.2021006302 |
_version_ | 1784633181157195776 |
---|---|
author | Okamoto, Akinao Fujigaki, Hidetsugu Iriyama, Chisako Goto, Naoe Yamamoto, Hideyuki Mihara, Keichiro Inaguma, Yoko Miura, Yasuo Furukawa, Katsuya Yamamoto, Yukiya Akatsuka, Yoshiki Kasahara, Senji Miyao, Kotaro Tokuda, Masutaka Sato, Seiko Mizutani, Yuki Osawa, Michiko Hattori, Keiko Iba, Sachiko Kajiya, Ryoko Okamoto, Masataka Saito, Kuniaki Tomita, Akihiro |
author_facet | Okamoto, Akinao Fujigaki, Hidetsugu Iriyama, Chisako Goto, Naoe Yamamoto, Hideyuki Mihara, Keichiro Inaguma, Yoko Miura, Yasuo Furukawa, Katsuya Yamamoto, Yukiya Akatsuka, Yoshiki Kasahara, Senji Miyao, Kotaro Tokuda, Masutaka Sato, Seiko Mizutani, Yuki Osawa, Michiko Hattori, Keiko Iba, Sachiko Kajiya, Ryoko Okamoto, Masataka Saito, Kuniaki Tomita, Akihiro |
author_sort | Okamoto, Akinao |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8759802 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-87598022022-01-18 CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma Okamoto, Akinao Fujigaki, Hidetsugu Iriyama, Chisako Goto, Naoe Yamamoto, Hideyuki Mihara, Keichiro Inaguma, Yoko Miura, Yasuo Furukawa, Katsuya Yamamoto, Yukiya Akatsuka, Yoshiki Kasahara, Senji Miyao, Kotaro Tokuda, Masutaka Sato, Seiko Mizutani, Yuki Osawa, Michiko Hattori, Keiko Iba, Sachiko Kajiya, Ryoko Okamoto, Masataka Saito, Kuniaki Tomita, Akihiro Blood Adv Research Letter American Society of Hematology 2022-05-31 /pmc/articles/PMC8759802/ /pubmed/35026843 http://dx.doi.org/10.1182/bloodadvances.2021006302 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://www.ncbi.nlm.nih.gov/pmc/pmcdoc/tagging-guidelines/article/tags.html#el-licenseThis article is made available via the PMC Open Access Subset for unrestricted reuse and analyses in any form or by any means with acknowledgment of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | Research Letter Okamoto, Akinao Fujigaki, Hidetsugu Iriyama, Chisako Goto, Naoe Yamamoto, Hideyuki Mihara, Keichiro Inaguma, Yoko Miura, Yasuo Furukawa, Katsuya Yamamoto, Yukiya Akatsuka, Yoshiki Kasahara, Senji Miyao, Kotaro Tokuda, Masutaka Sato, Seiko Mizutani, Yuki Osawa, Michiko Hattori, Keiko Iba, Sachiko Kajiya, Ryoko Okamoto, Masataka Saito, Kuniaki Tomita, Akihiro CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title | CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title_full | CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title_fullStr | CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title_full_unstemmed | CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title_short | CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma |
title_sort | cd19-positive lymphocyte count is critical for acquisition of anti-sars-cov-2 igg after vaccination in b-cell lymphoma |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759802/ https://www.ncbi.nlm.nih.gov/pubmed/35026843 http://dx.doi.org/10.1182/bloodadvances.2021006302 |
work_keys_str_mv | AT okamotoakinao cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT fujigakihidetsugu cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT iriyamachisako cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT gotonaoe cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT yamamotohideyuki cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT miharakeichiro cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT inagumayoko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT miurayasuo cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT furukawakatsuya cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT yamamotoyukiya cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT akatsukayoshiki cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT kasaharasenji cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT miyaokotaro cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT tokudamasutaka cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT satoseiko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT mizutaniyuki cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT osawamichiko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT hattorikeiko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT ibasachiko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT kajiyaryoko cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT okamotomasataka cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT saitokuniaki cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma AT tomitaakihiro cd19positivelymphocytecountiscriticalforacquisitionofantisarscov2iggaftervaccinationinbcelllymphoma |